123 related articles for article (PubMed ID: 2661501)
1. [Demonstration of S 100 protein in malignant melanoma of the skin. Pattern of distribution and significance for determination of tumor thickness].
Flügge G; Rassner G
Hautarzt; 1989 May; 40(5):290-5. PubMed ID: 2661501
[TBL] [Abstract][Full Text] [Related]
2. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
3. Angiomatoid melanoma: a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma.
Baron JA; Monzon F; Galaria N; Murphy GF
Hum Pathol; 2000 Dec; 31(12):1520-2. PubMed ID: 11150378
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistologic markers in the diagnosis and prognosis of malignant melanomas].
Suter L; Bröcker EB
Pathologe; 1987 May; 8(3):163-7. PubMed ID: 3303010
[No Abstract] [Full Text] [Related]
5. Fine needle aspiration biopsy of myxoid metastasis of malignant melanoma.
Rocamora A; Carrillo R; Vives R; Solera JC
Acta Cytol; 1988; 32(1):94-100. PubMed ID: 2447728
[TBL] [Abstract][Full Text] [Related]
6. [Value of high resolution ultrasound in determination of vertical tumor thickness in malignant melanoma of the skin].
Gassenmaier G; Kiesewetter F; Schell H; Zinner M
Hautarzt; 1990 Jul; 41(7):360-4. PubMed ID: 2205600
[TBL] [Abstract][Full Text] [Related]
7. [Malignant blue nevus].
Rupec R; Eckert F; Ruzicka T
Hautarzt; 1993 Mar; 44(3):164-6. PubMed ID: 8463099
[TBL] [Abstract][Full Text] [Related]
8. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
Pinto MM
Acta Cytol; 1986; 30(3):240-4. PubMed ID: 3521174
[TBL] [Abstract][Full Text] [Related]
9. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
10. Preoperative assessment of melanoma thickness by ABCD score of dermatoscopy.
Carli P; de Giorgi V; Palli D; Giannotti V; Giannotti B
J Am Acad Dermatol; 2000 Sep; 43(3):459-66. PubMed ID: 10954657
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
12. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma.
Barnhill RL; Castresana JS; Rubio MP; Martin MT; Idoate M; Vazquez JJ; Thor AD
Mod Pathol; 1994 Jun; 7(5):533-5. PubMed ID: 7937717
[TBL] [Abstract][Full Text] [Related]
14. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma.
Abraha HD; Fuller LC; Du Vivier AW; Higgins EM; Sherwood RA
Br J Dermatol; 1997 Sep; 137(3):381-5. PubMed ID: 9349333
[TBL] [Abstract][Full Text] [Related]
15. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
16. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
Kligora CJ; Fair KP; Clem MS; Patterson JW
Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
[TBL] [Abstract][Full Text] [Related]
17. [The pretherapeutic phase of malignant melanoma of the skin. Analysis and suggestions for improvements in early diagnosis].
Bern A; Rassner G
Z Hautkr; 1988 Apr; 63(4):273-81. PubMed ID: 3388931
[TBL] [Abstract][Full Text] [Related]
18. [Molecular markers associated to prognosis of melanoma].
Heenen M; Laporte M
Ann Dermatol Venereol; 2003 Nov; 130(11):1025-31. PubMed ID: 14724537
[TBL] [Abstract][Full Text] [Related]
19. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
20. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
